Finance

Beta
Lists
OS1:FRA
Otsuka Holdings Co Ltd
€57.00
-3.39%
(-2.00) 1D
Jun 4, 8:04:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for OS1...
Open
€57.50
High
€57.50
Low
€57.00
Mkt. cap
5.78T
Avg. vol.
22.00
Volume
0.00
52-wk high
€63.00
52-wk low
€37.60
No. of employees
38K
Open
€57.50
High
€57.50
Low
€57.00
Mkt. cap
5.78T
Avg. vol.
22.00
Volume
0.00
52-wk high
€63.00
52-wk low
€37.60
No. of employees
38K
News stories
From sources across the web
About Otsuka Holdings Co Ltd
CEO-
Employees37.8K
FoundedJul 8, 2008
Headquarters-
SectorPharmaceutical industry
Websiteotsuka.com
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
597.93B
637.98B
650.15B
630.34B
Cost of goods sold
168.78B
180.95B
192.74B
174.09B
Cost of revenue
168.78B
180.95B
192.74B
174.09B
Research and development expenses
84.52B
85.74B
104.19B
82.10B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
240.67B
253.75B
278.25B
259.49B
Operating expense
323.33B
287.73B
377.96B
338.04B
Total operating expenses
492.11B
468.69B
570.70B
512.13B
Operating income
105.82B
169.29B
79.45B
118.21B
Other non operating income
-
1.00M
-1.00M
-4.00M
EBT including unusual items
112.98B
166.43B
75.26B
130.22B
EBT excluding unusual items
112.22B
180.64B
87.47B
130.51B
Income tax expense
23.08B
40.87B
10.48B
30.93B
Effective tax rate
20.43%
24.56%
13.92%
23.75%
Other operating expenses
-1.86B
-51.76B
-4.48B
-3.56B
Net income
88.53B
124.13B
65.49B
98.35B
Net profit margin
14.81%
19.46%
10.07%
15.60%
Earnings per share
-
-
-
-
Interest and investment income
5.01B
2.47B
5.52B
5.98B
Interest expense
-9.73B
-1.34B
-2.21B
-2.04B
Net interest expenses
-4.72B
1.13B
3.31B
3.94B
Depreciation and amortization charges
-
-
-
-
EBITDA
133.84B
197.78B
111.97B
148.58B
Gain or loss from assets sale
531.00M
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more